Trial intelligence / Profile preview

OXY-PREEM: Initial Oxygen Concentration at Birth in Late-Preterm Infants

NCT07315594Not yet recruiting

Sponsor
University of Alberta
Start
Nov 2026
Primary completion
Jun 2029
Modality
Inhalation Devices
Countries
1
01

Overview

Randomised, open-label trial of oxygen in preterm birth (2 arms), sponsored by University of Alberta. Primary endpoint: Need for ongoing respiratory support at one hour after birth at 60 minutes. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

oxygen
03

Conditions

preterm birth

Beyond the preview

Go deeper on NCT07315594.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07315594.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call